NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis

Immunofluorescence mapping demonstrates that the NG2 proteoglycan is invariably expressed by the mural cell component of mouse neovascular structures. This pattern is independent of the developmental mechanism responsible for formation of the vasculature (vasculogenesis or angiogenesis). Thus, NG2 is expressed in the embryonic heart by cardiomyocytes, in developing macrovasculature by smooth muscle cells, and in nascent microvessels by vascular pericytes. Due to the scarcity of proven markers for developing pericytes, NG2 is especially useful for identification of this cell type. The utility of NG2 as a pericyte marker is illustrated by two observations. First, pericytes are associated with endothelial tubes at an early point in microvessel development. This early interaction between pericytes and endothelial cells has important implications for the role of pericytes in the development and stabilization of microvascular tubes. Second, the pericyte to endothelial cell ratio in developing capillaries varies from tissue to tissue. Because the extent of pericyte investment is likely to affect the physical properties of the vessel in question, it is important to understand the mechanisms that control this process. Additional insight into these and other aspects of vascular morphogenesis should be possible through use of NG2 as a mural cell marker. © 2001 Wiley‐Liss, Inc.

[1]  J. Lawrenson,et al.  Pericytes: Cell Biology and Pathology , 2001, Cells Tissues Organs.

[2]  C. Lombardo,et al.  Binding of the NG2 Proteoglycan to Kringle Domains Modulates the Functional Properties of Angiostatin and Plasmin(ogen)* , 2000, The Journal of Biological Chemistry.

[3]  C. Drake,et al.  Vasculogenesis in the day 6.5 to 9.5 mouse embryo. , 2000, Blood.

[4]  D. Barritt,et al.  Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. , 1999, Molecular biology of the cell.

[5]  R Pasqualini,et al.  NG2 proteoglycan-binding peptides target tumor neovasculature. , 1999, Cancer research.

[6]  W. Stallcup,et al.  High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan* , 1999, The Journal of Biological Chemistry.

[7]  T Ochiya,et al.  PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. , 1999, Journal of cell science.

[8]  K. Hirschi,et al.  Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. , 1999, Circulation research.

[9]  A. Moorman,et al.  Regionalization of Transcriptional Potential in the Myocardium , 1999 .

[10]  P. Dore‐Duffy,et al.  Role of the CNS microvascular pericyte in the blood‐brain barrier , 1998, Journal of neuroscience research.

[11]  K. Hirschi,et al.  PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.

[12]  P. Lindahl,et al.  Not all myofibroblasts are alike: revisiting the role of PDGF‐A and PDGF‐B using PDGF‐targeted mice , 1998, Current opinion in nephrology and hypertension.

[13]  A. Canfield,et al.  Marrow Stromal Cell Culture: Osteogenic potential of vascular pericytes , 1998 .

[14]  R. Glanville,et al.  Type VI Collagen Anchors Endothelial Basement Membranes by Interacting with Type IV Collagen* , 1997, The Journal of Biological Chemistry.

[15]  A. Nishiyama,et al.  A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. , 1997, Experimental cell research.

[16]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[17]  F. Ruggiero,et al.  The Membrane-spanning Proteoglycan NG2 Binds to Collagens V and VI through the Central Nonglobular Domain of Its Core Protein* , 1997, The Journal of Biological Chemistry.

[18]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[19]  P. D’Amore,et al.  Vascular Development: Cellular and Molecular Regulation , 2022 .

[20]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[21]  R. Timpl,et al.  Binding of the NG2 Proteoglycan to Type VI Collagen and Other Extracellular Matrix Molecules* , 1996, The Journal of Biological Chemistry.

[22]  G. Owens,et al.  Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. , 1996, Developmental biology.

[23]  D. S. Mcleod,et al.  Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. , 1996, Investigative ophthalmology & visual science.

[24]  C. Heldin,et al.  Co‐localization of NG2 proteoglycan and PDGF α‐receptor on O2A progenitor cells in the developing rat brain , 1996, Journal of neuroscience research.

[25]  W. Stallcup,et al.  Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. , 1995, Experimental cell research.

[26]  A. Pearlman,et al.  Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways , 1995, The Journal of comparative neurology.

[27]  P. Wesseling,et al.  Early and Extensive Contribution of Pericytes/Vascular Smooth Muscle Cells to Microvascular Proliferation in Glioblastoma Multiforme: An Immuno‐light and Immuno‐electron Microscopic Study , 1995, Journal of neuropathology and experimental neurology.

[28]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[29]  W. Pardridge,et al.  Differential expression of α‐actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells , 1994 .

[30]  D. Sims,et al.  Heterogeneity of Pericyte Populations in Equine Skeletal Muscle and Dermal Microvessels: A Quantitative Study , 1994, Anatomia, histologia, embryologia.

[31]  K. Chien,et al.  Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. , 1994, The Journal of biological chemistry.

[32]  W. Pardridge,et al.  Differential expression of alpha-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells. , 1994, Journal of neuroscience research.

[33]  A. Nishiyama,et al.  Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. , 1993, Molecular biology of the cell.

[34]  K. Chien,et al.  Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Gordon,et al.  Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium. , 1993, The American journal of pathology.

[36]  M. Schrappe,et al.  Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. , 1991, Cancer research.

[37]  A. Nishiyama,et al.  The expression of NG2 proteoglycan in the developing rat limb. , 1991, Development.

[38]  V Nehls,et al.  Heterogeneity of microvascular pericytes for smooth muscle type alpha- actin , 1991, The Journal of cell biology.

[39]  W. Stallcup,et al.  Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen , 1990, The Journal of cell biology.

[40]  V. Sukhatme,et al.  Alpha- and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response. , 1990, The Journal of biological chemistry.

[41]  D. Rifkin,et al.  Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self- regulating system , 1990, The Journal of cell biology.

[42]  S Ferrone,et al.  Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. , 1989, The American journal of pathology.

[43]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[44]  I. Herman,et al.  Functional sorting of actin isoforms in microvascular pericytes , 1989, The Journal of cell biology.

[45]  Sandra R. Smith,et al.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. King,et al.  A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes , 1988, The Journal of experimental medicine.

[47]  P A D'Amore,et al.  Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells , 1987, The Journal of cell biology.

[48]  R W Flower,et al.  Visualization of a developing vasculature. , 1987, Microvascular research.

[49]  A. Ullrich,et al.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors , 1986, Nature.

[50]  D. Sims,et al.  The pericyte--a review. , 1986, Tissue & cell.

[51]  C. Kilo,et al.  Pericyte-endothelial relationships in cardiac and skeletal muscle capillaries. , 1979, Microvascular research.

[52]  M. Grim,et al.  Mesenchymal derivatives of the neural crest: analysis of chimaeric quail and chick embryos. , 1975 .

[53]  N. L. Le Douarin,et al.  Mesenchymal derivatives of the neural crest: analysis of chimaeric quail and chick embryos. , 1975, Journal of embryology and experimental morphology.

[54]  A. Patz,et al.  Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes. , 1968, Archives of ophthalmology.

[55]  K. Kojima [Studies on diabetic retinopathy]. , 1966, Nippon Ganka Gakkai zasshi.